{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:16:03Z","timestamp":1772460963512,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T00:00:00Z","timestamp":1243814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1016\/j.molimm.2008.12.031","type":"journal-article","created":{"date-parts":[[2009,4,8]],"date-time":"2009-04-08T08:36:04Z","timestamp":1239179764000},"page":"2107-2115","source":"Crossref","is-referenced-by-count":33,"title":["Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis"],"prefix":"10.1016","volume":"46","author":[{"given":"Manpreet","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hema","family":"Chug","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harpreet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subhash","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meenakshi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2008.12.031_bib1","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.1128\/IAI.00884-07","article-title":"Recombinant exosporium protein BclA of Bacillus anthracis is effective as a booster for mice primed with suboptimal amounts of protective antigen","volume":"75","author":"Brahmbhatt","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2008.12.031_bib2","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.addr.2005.01.028","article-title":"Molecular basis for improved anthrax vaccines","volume":"57","author":"Brey","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.molimm.2008.12.031_bib3","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1128\/IAI.69.7.4509-4515.2001","article-title":"Protection against anthrax lethal toxin challenge by genetic immunization with a plasmid encoding the lethal factor protein","volume":"69","author":"Brian","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2008.12.031_bib4","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1128\/IAI.67.2.964-967.1999","article-title":"Functional analysis of the carboxy-terminal domain of Bacillus anthracis protective antigen","volume":"67","author":"Brossier","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2008.12.031_bib5","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1128\/IAI.68.10.5731-5734.2000","article-title":"Protective antigen mediated antibody response against a heterologous protein produced in vivo by Bacillus anthracis","volume":"68","author":"Brossier","year":"2000","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2008.12.031_bib6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1006\/bbrc.2001.4777","article-title":"Constitutive expression of protective antigen gene of Bacillus anthracis in Escherichia coli","volume":"283","author":"Chauhan","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molimm.2008.12.031_bib7","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.vaccine.2005.08.002","article-title":"Candidate peptide vaccine induced potent protection against CSFV and identified a principal sequential neutralizing determinant on E2","volume":"24","author":"Dong","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2008.12.031_bib8","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/S0264-410X(00)00452-7","article-title":"New strategies for closing the gap of measles susceptibility in infants: towards vaccines compatible with current vaccination schedules","volume":"19","author":"El Kasmi","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2008.12.031_bib9","doi-asserted-by":"crossref","first-page":"6706","DOI":"10.1021\/bi000310u","article-title":"A quantitative study of the interactions of Bacillus anthracis edema factor and lethal factor with activated protective antigen","volume":"39","author":"Elliott","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.molimm.2008.12.031_bib10","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1128\/JVI.01409-07","article-title":"Phase I trial of a CD8+ T-cell peptide epitope-based vaccine for infectious mononucleosis","volume":"82","author":"Elliott","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2008.12.031_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jmr.893","article-title":"Predicting linear B-cell epitopes using string kernels","volume":"21","author":"EL-Manzalawy","year":"2008","journal-title":"J. Mol. Recognit."},{"key":"10.1016\/j.molimm.2008.12.031_bib12","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1128\/IAI.59.10.3381-3386.1991","article-title":"Anthrax protective antigen interacts with a specific receptor on the surface of CHO-K1 cells","volume":"59","author":"Escuyer","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2008.12.031_bib13","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.1128\/JVI.67.10.5843-5848.1993","article-title":"Influence of epitope polarity and adjuvants on the immunogenicity and efficacy of a synthetic peptide vaccine against Semliki Forest virus","volume":"67","author":"Fernandez","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.molimm.2008.12.031_bib14","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1128\/IAI.70.3.1653-1656.2002","article-title":"A recombinant carboxy-terminal domain of the protective antigen of Bacillus anthracis protects mice against anthrax infection","volume":"70","author":"Flick-Smith","year":"2002","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2008.12.031_bib15","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0022-1759(85)90044-4","article-title":"Measurements of the true affinity constant in solution of antigen\u2013antibody complexes by enzyme-linked immunosorbent assay","volume":"77","author":"Friguet","year":"1985","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2008.12.031_bib16","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1089\/aid.2006.22.684","article-title":"New CD4+ and CD8+ T cell responses induced in chronically HIV type-1-infected patients after immunizations with an HIV type 1 lipopeptide vaccine","volume":"22","author":"Gahery","year":"2006","journal-title":"AIDS Res. Hum. Retroviruses"},{"key":"10.1016\/j.molimm.2008.12.031_bib17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0264-410X(98)00210-2","article-title":"Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen","volume":"17","author":"Gu","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2008.12.031_bib18","doi-asserted-by":"crossref","first-page":"66862","DOI":"10.1128\/IAI.66.2.862-865.1998","article-title":"Expression and purification of the recombinant lethal factor of Bacillus anthracis","volume":"66","author":"Gupta","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2008.12.031_bib19","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1099\/0022-1317-80-6-1401","article-title":"Synergistic effect of immunization a peptide cocktail inducing antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus","volume":"80","author":"Hsu","year":"1999","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.molimm.2008.12.031_bib20","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.molimm.2008.12.031_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0939-6411(00)00079-5","article-title":"Revisiting PLA\/PLGA microspheres: an analysis of their potential in parenteral vaccination","volume":"50","author":"Johansen","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.molimm.2008.12.031_bib22","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.vaccine.2007.11.028","article-title":"Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune response of V antigen of Yersinia pestis","volume":"26","author":"Khan","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2008.12.031_bib23","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/10870","article-title":"Vaccination with carbohydrate peptide mimotopes promotes anti-tumor responses","volume":"17","author":"Kieber-Emmons","year":"1999","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molimm.2008.12.031_bib24","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0264-410X(02)00037-3","article-title":"Delayed-type hypersensitivity in volunteers immunized with a synthetic multi-antigen peptide vaccine (PfCS-MAP1NYU) against Plasmodium falciparum sporozoites","volume":"20","author":"Kublin","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2008.12.031_bib25","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1128\/AAC.49.8.3414-3420.2005","article-title":"Selection of a macaque Fab with framework regions like those in humans, high affinity, and ability to neutralize the protective antigen (PA) of Bacillus anthracis by binding to the segment of PA between residues 686 and 694","volume":"49","author":"Laffly","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.molimm.2008.12.031_bib26","doi-asserted-by":"crossref","first-page":"3162","DOI":"10.1073\/pnas.79.10.3162","article-title":"Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells","volume":"79","author":"Leppla","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.molimm.2008.12.031_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI0216204","article-title":"Development of an improved vaccine for anthrax","volume":"110","author":"Leppla","year":"2002","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.molimm.2008.12.031_bib28","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/intimm\/dxh305","article-title":"A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice","volume":"17","author":"Li","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.molimm.2008.12.031_bib29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S1286-4579(99)80004-5","article-title":"Molecular pathogenesis of Bacillus anthracis infection","volume":"2","author":"Little","year":"1999","journal-title":"Microbes Infect."},{"key":"10.1016\/j.molimm.2008.12.031_bib30","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1128\/IAI.56.7.1807-1813.1988","article-title":"Production and characterization of monoclonal antibodies to the protective antigen of Bacillus anthracis toxin","volume":"56","author":"Little","year":"1988","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2008.12.031_bib31","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1099\/13500872-142-3-707","article-title":"Characterization of lethal factor binding and cell receptor binding domains of protective antigen of Bacillus anthracis using monoclonal antibodies","volume":"142","author":"Little","year":"1996","journal-title":"Microbiology"},{"key":"10.1016\/j.molimm.2008.12.031_bib32","first-page":"289","article-title":"Immune responses to six synthetic peptides of capsid protein with sera from HIV-1 infected individuals","volume":"2","author":"Liu","year":"2005","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.molimm.2008.12.031_bib33","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0264-410X(97)00268-5","article-title":"Protective efficacy of a recombinant protective antigen against Bacillus anthracis challenge and assessment of immunological markers","volume":"16","author":"McBride","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2008.12.031_bib34","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","article-title":"Anthrax","volume":"55","author":"Mock","year":"2001","journal-title":"Annu. Rev. Microbiol."},{"key":"10.1016\/j.molimm.2008.12.031_bib35","doi-asserted-by":"crossref","first-page":"52425","DOI":"10.1074\/jbc.M309034200","article-title":"Differential processing of CD4 T-cell epitopes from the protective antigen of Bacillus anthracis","volume":"278","author":"Musson","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2008.12.031_bib36","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1086\/315871","article-title":"Synthetic malaria peptide vaccine e high levels of antibodies in vaccinees of defined HLA genotypes","volume":"182","author":"Nardin","year":"2000","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.molimm.2008.12.031_bib37","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4049\/jimmunol.161.1.200","article-title":"A partially modified retro-inverso pseudopeptide modulates the cytokine profile of CTL specific for an influenza virus epitope","volume":"161","author":"Ostankovitch","year":"1998","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2008.12.031_bib38","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1128\/IAI.01722-07","article-title":"Enhancement of antibody responses to Bacillus anthracis protective antigen domain IV by use of calreticulin as a chimeric molecular adjuvant","volume":"76","author":"Park","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2008.12.031_bib39","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.virusres.2008.04.003","article-title":"Identification of a conserved linear B-cell epitope at the N-terminus of the E2 glycoprotein of Classical swine fever virus by phage-displayed random peptide library","volume":"35","author":"Peng","year":"2008","journal-title":"Virus Res."},{"key":"10.1016\/j.molimm.2008.12.031_bib40","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/385833a0","article-title":"Crystal structure of the anthrax toxin protective antigen","volume":"385","author":"Petosa","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.molimm.2008.12.031_bib41","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1046\/j.1365-2672.1999.00897.x","article-title":"In vitro correlate of immunity in an animal model of inhalational anthrax","volume":"87","author":"Pitt","year":"1999","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.molimm.2008.12.031_bib42","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0022-1759(86)90268-1","article-title":"Antibody avidity determination by ELISA using thiocyanate elution","volume":"86","author":"Pullen","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2008.12.031_bib43","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1365-2567.2004.01873.x","article-title":"Induction of immune responses against human papillomaviruses by hypervariable epitope constructs","volume":"112","author":"Reddy","year":"2004","journal-title":"Immunology"},{"key":"10.1016\/j.molimm.2008.12.031_bib44","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.1128\/IAI.69.5.2888-2893.2001","article-title":"Search for correlates of protective immunity conferred by anthrax vaccine","volume":"69","author":"Reuveny","year":"2001","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2008.12.031_bib45","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ijpharm.2006.11.063","article-title":"PLGA-dendron nanoparticles enhance immunogenicity but not lethal antibody production of a DNA vaccine against anthrax in mice","volume":"331","author":"Ribeiro","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.molimm.2008.12.031_bib46","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0928-8244(03)00170-6","article-title":"Developing subunit immunogens using B and T cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles","volume":"38","author":"Sabhnani","year":"2003","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"10.1016\/j.molimm.2008.12.031_bib47","doi-asserted-by":"crossref","unstructured":"Saha, S., Raghava, G.P.S., 2004. BcePRED: prediction of continuous B-Cell epitopes in antigenic sequences using physico-chemical properties. In: Nicosia, G., Cutello, V., Bentley, P.J., Timis, J. (Eds.), ICARIS, LNCS 3239, pp. 197\u2013204.","DOI":"10.1007\/978-3-540-30220-9_16"},{"key":"10.1016\/j.molimm.2008.12.031_bib48","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2222.1999.00612.x","article-title":"Allergy to bovine beta lactoglobulin: specificity of human IgE to tryptic peptides","volume":"29","author":"Selo","year":"1999","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.molimm.2008.12.031_bib49","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1517\/14712598.4.4.483","article-title":"Charged polylactide-co-glycolide microparticles as antigen delivery systems","volume":"4","author":"Singh","year":"2004","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.molimm.2008.12.031_bib50","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1099\/00221287-26-1-49","article-title":"Purification of factor I and recognition of a third factor of the anthrax toxin","volume":"26","author":"Stanley","year":"1961","journal-title":"J. Gen. Microbiol."},{"key":"10.1016\/j.molimm.2008.12.031_bib51","doi-asserted-by":"crossref","first-page":"24141","DOI":"10.1074\/jbc.M313210200","article-title":"De novo design of peptide immunogens that mimic the coiled coil region of human T-cell leukemia virus type-1 glycoprotein 21 transmembrane subunit for induction of native protein reactive neutralizing antibodies","volume":"279","author":"Sundaram","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.molimm.2008.12.031_bib52","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1016\/j.vaccine.2006.01.031","article-title":"Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery","volume":"24","author":"Tripathi","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.molimm.2008.12.031_bib53","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1128\/IAI.67.4.1860-1865.1999","article-title":"Identification of a receptor-binding region within domain 4 of the protective antigen component of anthrax toxin","volume":"67","author":"Varughese","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.molimm.2008.12.031_bib54","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1006\/bbrc.1998.9040","article-title":"Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces tyrosine\/threonine phosphorylation of MAPKs in cultured macrophages","volume":"248","author":"Vitale","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.molimm.2008.12.031_bib55","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0165-2478(01)00187-0","article-title":"Epitope-vaccine as a new strategy against HIV-1 mutation","volume":"77","author":"Xiao","year":"2001","journal-title":"Immunol. Lett."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589009000054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589009000054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T13:29:31Z","timestamp":1710250171000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589009000054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["S0161589009000054"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2008.12.031","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}